1
|
Xie Z, Chen J, Or CK. Consumers’ Willingness to Pay for eHealth and Its Influencing Factors: Systematic Review and Meta-analysis. J Med Internet Res 2022; 24:e25959. [PMID: 36103227 PMCID: PMC9520394 DOI: 10.2196/25959] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/22/2020] [Revised: 06/15/2022] [Accepted: 08/11/2022] [Indexed: 11/13/2022] Open
Abstract
Background Despite the great potential of eHealth, substantial costs are involved in its implementation, and it is essential to know whether these costs can be justified by its benefits. Such needs have led to an increased interest in measuring the benefits of eHealth, especially using the willingness to pay (WTP) metric as an accurate proxy for consumers’ perceived benefits of eHealth. This offered us an opportunity to systematically review and synthesize evidence from the literature to better understand WTP for eHealth and its influencing factors. Objective This study aimed to provide a systematic review of WTP for eHealth and its influencing factors. Methods This study was performed and reported as per the Cochrane Collaboration and PRISMA (Preferred Reporting Items for Systematic Reviews and Meta-Analyses) guidelines. PubMed, CINAHL Plus, Cochrane Library, EconLit, and PsycINFO databases were searched from their inception to April 19, 2022. We conducted random-effects meta-analyses to calculate WTP values for eHealth (at 2021 US dollar rates) and meta-regression analyses to examine the factors affecting WTP. Results A total of 30 articles representing 35 studies were included in the review. We found that WTP for eHealth varied across studies; when expressed as a 1-time payment, it ranged from US $0.88 to US $191.84, and when expressed as a monthly payment, it ranged from US $5.25 to US $45.64. Meta-regression analyses showed that WTP for eHealth was negatively associated with the percentages of women (β=−.76; P<.001) and positively associated with the percentages of college-educated respondents (β=.63; P<.001) and a country’s gross domestic product per capita (multiples of US $1000; β=.03; P<.001). Compared with eHealth provided through websites, people reported a lower WTP for eHealth provided through asynchronous communication (β=−1.43; P<.001) and a higher WTP for eHealth provided through medical devices (β=.66; P<.001), health apps (β=.25; P=.01), and synchronous communication (β=.58; P<.001). As for the methods used to measure WTP, single-bounded dichotomous choice (β=2.13; P<.001), double-bounded dichotomous choice (β=2.20; P<.001), and payment scale (β=1.11; P<.001) were shown to obtain higher WTP values than the open-ended format. Compared with ex ante evaluations, ex post evaluations were shown to obtain lower WTP values (β=−.37; P<.001). Conclusions WTP for eHealth varied significantly depending on the study population, modality used to provide eHealth, and methods used to measure it. WTP for eHealth was lower among certain population segments, suggesting that these segments may be at a disadvantage in terms of accessing and benefiting from eHealth. We also identified the modalities of eHealth that were highly valued by consumers and offered suggestions for the design of eHealth interventions. In addition, we found that different methods of measuring WTP led to significantly different WTP estimates, highlighting the need to undertake further methodological explorations of approaches to elicit WTP values.
Collapse
Affiliation(s)
- Zhenzhen Xie
- Department of Industrial and Manufacturing Systems Engineering, The University of Hong Kong, Hong Kong, China (Hong Kong)
| | - Jiayin Chen
- Department of Industrial and Manufacturing Systems Engineering, The University of Hong Kong, Hong Kong, China (Hong Kong)
| | - Calvin Kalun Or
- Department of Industrial and Manufacturing Systems Engineering, The University of Hong Kong, Hong Kong, China (Hong Kong)
| |
Collapse
|
2
|
Shouman S, Emara T, Saber HG, Allam MF. Awareness and attitude of primary healthcare patients towards telehealth in Cairo, Egypt. Curr Med Res Opin 2022; 38:993-998. [PMID: 35404179 DOI: 10.1080/03007995.2022.2065141] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/03/2022]
Abstract
BACKGROUND Telehealth is delivering health care services remotely from healthcare facilities using telecommunications and virtual technology. Egypt is aiming to reach Universal Health Coverage; this increases the demand for telehealth in routine health services. Telehealth helps in increasing access to areas with no available medical services as patients can be monitored remotely. OBJECTIVE To measure the awareness of telehealth among attendees of primary health care units and their acceptance of applying telehealth. METHODOLOGY This was a cross-sectional study among attendees of primary health units. Ethical issues were considered. RESULTS A sample size was calculated to be 162 and 170 valid Arabic interview questionnaires were filled by attendees. The awareness percentage of telehealth among attendees was 64.7% while the willingness to implement telehealth was 78%. Both awareness and willingness were significantly associated with age groups, residence, socioeconomic status, and presence of computer with internet access. Age, residence, and possession of a PC were the only adjusted predictive factors for knowledge about telehealth among patients in the multivariable analysis. CONCLUSION Large percentages of attendees to primary health care centers are aware of telehealth and are willing to implement it. The major cause of refusal to implement telehealth was ignorance of using telecommunication devices and the desire to be in close contact with the physicians.
Collapse
Affiliation(s)
- Sara Shouman
- Department of Family Medicine, Faculty of Medicine, Ain Shams University, Cairo, Egypt
| | - Tamer Emara
- Department of Neurology, Faculty of Medicine, Ain Shams University, Cairo, Egypt
| | - Heba Gamal Saber
- Department of Geriatrics and Gerontology, Faculty of Medicine, Ain Shams University, Cairo, Egypt
| | - Mohamed Farouk Allam
- Department of Family Medicine, Faculty of Medicine, Ain Shams University, Cairo, Egypt
| |
Collapse
|
3
|
Poirier B, Jensen E, Sethi S. The evolution of the teledentistry landscape in Australia: A scoping review. Aust J Rural Health 2022; 30:434-441. [PMID: 35567780 PMCID: PMC9542832 DOI: 10.1111/ajr.12874] [Citation(s) in RCA: 2] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/06/2022] [Revised: 03/24/2022] [Accepted: 04/06/2022] [Indexed: 01/18/2023] Open
Abstract
INTRODUCTION There has been a recent surge in the use of teledentistry services in Australia that has paralleled the COVID-19 pandemic. Due to the limited published literature reflecting on this transition, this article employed a systematic scoping review methodology. OBJECTIVE The objective was to explore the role of teledentistry in the provision of clinical dental services in Australia. DESIGN Two independent reviewers searched PubMed, Embase, Scopus, Web of Science and grey literature sources to identify literature eligible for inclusion. The search was restricted to Australia and service delivery. Data were categorically synthesised by modalities and reported benefits and limitations; findings were cross-referenced with the COVID-19 pandemic timeline. FINDINGS The systematic search identified 758 articles, of which 25 met the inclusion criteria. Results highlight a range of service providers and definitions of teledentistry. A shift in modality from asynchronous towards synchronous teledentistry pre- and post-COVID-19 pandemic is detailed. DISCUSSION Whilst highly useful during the COVID-19 pandemic, teledentistry provides a unique opportunity to continue to increase the accessibility of dental services, especially for patients in rural areas or those who are immunocompromised. CONCLUSION Clinicians and researchers must consider opportunities to merge existing research with the recent clinical uptake of teledentistry for patients that would benefit from teledental services beyond the COVID-19 pandemic.
Collapse
Affiliation(s)
- Brianna Poirier
- Adelaide Dental School, The University of Adelaide, Adelaide, South Australia, Australia
| | - Emilija Jensen
- Adelaide Dental School, The University of Adelaide, Adelaide, South Australia, Australia.,Department of Paediatric Dentistry, Women's and Children's Hospital, Adelaide, South Australia, Australia
| | - Sneha Sethi
- Adelaide Dental School, The University of Adelaide, Adelaide, South Australia, Australia
| |
Collapse
|
4
|
Farnham A, Baroutsou V, Hatz C, Fehr J, Kuenzli E, Blanke U, Puhan MA, Bühler S. Travel behaviours and health outcomes during travel: Profiling destination-specific risks in a prospective mHealth cohort of swiss travellers. Travel Med Infect Dis 2022; 47:102294. [PMID: 35247578 DOI: 10.1016/j.tmaid.2022.102294] [Citation(s) in RCA: 5] [Impact Index Per Article: 2.5] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/21/2021] [Revised: 02/01/2022] [Accepted: 02/28/2022] [Indexed: 11/24/2022]
Abstract
BACKGROUND We used a mobile application to determine the incidence of health events and risk behaviours during travel by country and identify which health risks are significantly elevated during travel compared with at home. METHOD TOURIST2 is a prospective cohort study of 1000 adult travellers from Switzerland to Thailand, India, China, Tanzania, Brazil and Peru, planning travel of ≤4 weeks between 09/2017 and 04/2019. The incidence rate ratio (IRR) in each country was calculated. RESULTS All countries had significantly higher incidence of health events than at home. The most elevated symptoms were sunburn, itching from mosquitoes, and gastrointestinal disorders (e.g. vomiting, diarrhoea), corresponding with universally high food/drink risk behaviours. Peru had the highest incidence of both overall negative health events and severe health events (172.0/1000 travel-days). Traffic accidents were significantly higher in Peru (IRR: 2.4, 1.2, 4.7), although incidence of transportation risk was highest in India and Thailand. In Tanzania, incidence of negative mental health events was significantly lower than at home, although it was elevated in other countries. Sexual risk behaviours were high in Brazil. CONCLUSIONS Our study improves the understanding of the non-infectious disease related health challenges travellers face and provides evidence for more personalised traveller support.
Collapse
Affiliation(s)
- Andrea Farnham
- Department of Public Health & Global Health, Division of Infectious Diseases, Epidemiology, Biostatistics and Prevention Institute, University of Zurich, 8001, Zurich, Switzerland; Swiss Tropical and Public Health Institute, CH-4123, Basel, Switzerland; University of Basel, CH-4004, Basel, Switzerland.
| | - Vasiliki Baroutsou
- Department of Public Health & Global Health, Division of Infectious Diseases, Epidemiology, Biostatistics and Prevention Institute, University of Zurich, 8001, Zurich, Switzerland; Department of Clinical Research, Faculty of Medicine, University of Basel, 4055, Basel, Switzerland
| | - Christoph Hatz
- Department of Public Health & Global Health, Division of Infectious Diseases, Epidemiology, Biostatistics and Prevention Institute, University of Zurich, 8001, Zurich, Switzerland; Swiss Tropical and Public Health Institute, CH-4123, Basel, Switzerland; University of Basel, CH-4004, Basel, Switzerland
| | - Jan Fehr
- Department of Public Health & Global Health, Division of Infectious Diseases, Epidemiology, Biostatistics and Prevention Institute, University of Zurich, 8001, Zurich, Switzerland
| | - Esther Kuenzli
- Department of Public Health & Global Health, Division of Infectious Diseases, Epidemiology, Biostatistics and Prevention Institute, University of Zurich, 8001, Zurich, Switzerland; Swiss Tropical and Public Health Institute, CH-4123, Basel, Switzerland; University of Basel, CH-4004, Basel, Switzerland
| | - Ulf Blanke
- ETH Zurich, Swiss Federal Institute of Technology, 8092, Zurich, Switzerland
| | - Milo A Puhan
- Department of Public Health & Global Health, Division of Infectious Diseases, Epidemiology, Biostatistics and Prevention Institute, University of Zurich, 8001, Zurich, Switzerland
| | - Silja Bühler
- Department of Public Health & Global Health, Division of Infectious Diseases, Epidemiology, Biostatistics and Prevention Institute, University of Zurich, 8001, Zurich, Switzerland; Department of Tropical Medicine, Bernhard Nocht Institute for Tropical Medicine, 20359, Hamburg, Germany; Division of Hygiene and Infectious Diseases, Institute of Hygiene and Environment, 20539, Hamburg, Germany
| |
Collapse
|
5
|
Aluzaite K, Greveson K, Ben-Horin S, Leong R, Haj O, Schultz M. Barriers to international travel in inflammatory bowel disease patients. J Travel Med 2021; 28:5981731. [PMID: 33188596 DOI: 10.1093/jtm/taaa197] [Citation(s) in RCA: 6] [Impact Index Per Article: 2.0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 08/24/2020] [Revised: 09/24/2020] [Accepted: 09/28/2020] [Indexed: 12/13/2022]
Abstract
BACKGROUND Inflammatory bowel disease poses substantial challenges to travel. We aimed to investigate inflammatory bowel diseases (IBD)-associated challenges to travel, information-seeking behaviour and associated factors. METHODS We collected data on patients' demographics, disease characteristics, travel barriers, information-seeking behaviour and travel outcomes in UK, Australia, New Zealand and Israel (2016-2018). Summary statistics were used to describe the sample, whereas multivariate binary and nominal logistic regression were used to model the outcome variables. RESULTS Almost 75.4% (1878/2491) participants' data were analysed with 71.14%, 15.4%, 11.2% and 2.1% from UK, Australia, NZ and Israel, respectively (76.3% females, 48.2% 30-49 years old 58.8% Crohn's disease). About 7.7% of study participants sought medical advice/were hospitalised while overseas. About 43.8% cancelled/changed their plans due to IBD. The most common barriers were worry about toilet facilities (76.3%), cleanliness/sanitation (50.9%) and availability of medical care (41.1%). Only 60.5% sought travel advice; the most popular information source was IBD doctor/nurse (32.6%). Almost 32.6% of study participants did not get travel insurance that covered their IBD. Those who did not receive advice or found obtaining travel insurance difficult, were less likely to obtain travel insurance (P < 0.001). Participants who travelled for work were more likely to be hospitalised/seek medical advice overseas and not obtain travel insurance. CONCLUSIONS We report a detailed investigation on the IBD-associated barriers while travelling abroad, common information-seeking behaviours and factors associated with worse outcomes. Importantly, patients from all the surveyed countries provided similar travel barrier and preparation habits, highlighting the consistent nature of the challenge.
Collapse
Affiliation(s)
- Kristina Aluzaite
- Department of Medicine, Dunedin School of Medicine, University of Otago, Dunedin Medical Campus, PO Box 56, Dunedin 9054, New Zealand
| | - Kay Greveson
- Gastroenterology Department, Royal Free Hospital NHS Foundation Trust Centre of Gastroenterology, Pond St, Hampstead, London NW3 2QG, UK
| | - Shomron Ben-Horin
- Sheba Medical Center and Sackler School of Medicine, Tel-Aviv University, Derech Sheba 2, Tel Hashomer, 52619, Israel
| | - Rupert Leong
- Gastroenterology and Liver Services, Concord Hospital, University of Sydney, Hospital Rd, Concord NSW 2139, Australia
| | - Ola Haj
- Sheba Medical Center and Sackler School of Medicine, Tel-Aviv University, Derech Sheba 2, Tel Hashomer, 52619, Israel
| | - Michael Schultz
- Department of Medicine, Dunedin School of Medicine, University of Otago, Dunedin Medical Campus, PO Box 56, Dunedin 9054, New Zealand
| |
Collapse
|
6
|
Rozenberg G, Petersiel N, Korytny A, Bishop B, Mousa A, Fried C, Maister A, Neuberger A. Standard pre-travel consultation versus shorter consultation combined with smartphone support: a randomized controlled trial. J Travel Med 2019; 26:5424971. [PMID: 30937447 DOI: 10.1093/jtm/taz025] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.6] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 12/19/2018] [Revised: 03/28/2019] [Accepted: 03/29/2019] [Indexed: 11/12/2022]
Abstract
Immediate and long-term recalls of a pre-travel consultation are suboptimal. We aimed to assess the role of online consultation for travellers. We randomized travellers into two study groups. In the intervention arm, each traveller was given a short pre-travel consultation of 8-12 minutes, combined with the option of smartphone support before and during the trip. In the control arm, each traveller was given a standard length pre-travel consultation of 18-22 minutes. Endpoints included knowledge about potential risks, travellers' satisfaction, time allocated to each traveller and clinical events. We enrolled 75 patients in the intervention group and 74 patients in the control group. Online consultation was used 33 times, by 24 travellers, both before and during the trip. Important health hazards that were addressed included animal and insect bites (8), treatment of diarrhea (4), malaria prophylaxis (2) and altitude sickness prophylaxis (5). Other consultations consisted mainly of reassurances of worried travellers and provision of data. Knowledge about travel-related risks was higher in the control group before travelling (8.86 ± 1.12 vs 8.34 ± 1.32, P = 0.014), and there was a trend towards higher levels of knowledge also during the trip (8.29 ± 1.35 vs 7.89 ± 1.39, P = 0.06). Travellers' satisfaction before and during the trip was similar in both groups: median 10 (10, 10) in both groups before traveling (P = 0.51) and median 9 (8, 10) in both groups during the trip (P = 0.71). In the intervention group, time allocated to each traveller was <12 minutes. There were no differences in the number of clinical events (P > 0.2 for all comparisons). Online WhatsApp support addressed several important travel-related hazards but, when combined with a shortened pre-travel consultation, was associated with a lower level of knowledge about health risks. Therefore, such smartphone support should augment, rather than replace, pre-travel consultation.
Collapse
Affiliation(s)
- Gilad Rozenberg
- Travel Medicine and Tropical Diseases Clinic, Division of Infectious Diseases, Rambam Medical Center, Haifa, Israel.,Bruce Rappaport Faculty of Medicine, Technion, Haifa, Israel
| | - Neta Petersiel
- Travel Medicine and Tropical Diseases Clinic, Division of Infectious Diseases, Rambam Medical Center, Haifa, Israel.,Internal Medicine H, Rambam Medical Center, Haifa, Israel
| | - Alexander Korytny
- Travel Medicine and Tropical Diseases Clinic, Division of Infectious Diseases, Rambam Medical Center, Haifa, Israel.,Internal Medicine H, Rambam Medical Center, Haifa, Israel
| | - Boaz Bishop
- Travel Medicine and Tropical Diseases Clinic, Division of Infectious Diseases, Rambam Medical Center, Haifa, Israel.,Internal Medicine B, Rambam Medical Center, Haifa, Israel.,Department of Nephrology, Rambam Medical Center, Haifa, Israel
| | - Amjad Mousa
- Travel Medicine and Tropical Diseases Clinic, Division of Infectious Diseases, Rambam Medical Center, Haifa, Israel.,Internal Medicine B, Rambam Medical Center, Haifa, Israel
| | - Carmit Fried
- Travel Medicine and Tropical Diseases Clinic, Division of Infectious Diseases, Rambam Medical Center, Haifa, Israel.,Internal Medicine B, Rambam Medical Center, Haifa, Israel
| | - Alina Maister
- Travel Medicine and Tropical Diseases Clinic, Division of Infectious Diseases, Rambam Medical Center, Haifa, Israel.,Internal Medicine B, Rambam Medical Center, Haifa, Israel
| | - Ami Neuberger
- Travel Medicine and Tropical Diseases Clinic, Division of Infectious Diseases, Rambam Medical Center, Haifa, Israel.,Bruce Rappaport Faculty of Medicine, Technion, Haifa, Israel.,Internal Medicine B, Rambam Medical Center, Haifa, Israel
| |
Collapse
|